Actively Recruiting

Phase Not Applicable
Age: 35Years +
All Genders
NCT07144761

Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™

Led by Osheru Inc. · Updated on 2025-08-27

200

Participants Needed

5

Research Sites

17 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The objective of this study is to evaluate patient-reported outcomes, surgeon reported outcomes, bruising, symmetry, the success of tissue adhesive for wound closure, and case time.

CONDITIONS

Official Title

Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™

Who Can Participate

Age: 35Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Provide signed written consent prior to participation in any study-related procedures.
  • Ability, comprehension, and willingness to follow study instructions, and likely to complete all study visits.
  • Male or female adults, 63 35 years old at the Preoperative Visit
  • Willing to return for required follow-up visits.
  • Subjects with excess eyelid skin are eligible to undergo the procedure in the opinion of the investigator.
  • Female subjects must be 1-year postmenopausal, surgically sterilized, or, if of childbearing potential, have a negative urine pregnancy test at the Preoperative Visit.
  • Women of childbearing potential must use an acceptable form of contraception throughout the study, including intrauterine, hormonal, barrier with spermicide, or abstinence.
Not Eligible

You will not qualify if you...

  • Subjects with a current Ptosis diagnosis
  • Subjects with a history of Graves' Disease
  • Subjects with Myasthenia Gravis
  • Subjects that in the opinion of the investigator are anatomically not conducive to using devices (e.g., heavy brow, severe hollowing of the upper eyelid, history of ocular or orbital trauma).
  • Subjects that have had any previous surgery eyelid or eyebrow region.
  • Use of anticoagulation therapy, including Aspirin, NSAIDS, Ibuprofen within 7 days and Xarelto, Warfarin, Enoxaparin, Plavix within 3 days prior to planned study procedure.
  • Active or recent (within 3 months) tobacco user
  • Allergy to adhesive glue
  • Participation in any study of an investigational, interventional product within 30 days prior to the Preoperative Visit or at any time during the study period.
  • Pregnant or nursing females.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

Center for Excellence in Eye Care

Miami, Florida, United States, 33176

Actively Recruiting

2

Vance Thompson Vision

Alexandria, Minnesota, United States, 56308

Actively Recruiting

3

Eye Care Specialists

Kingston, Pennsylvania, United States, 18704

Actively Recruiting

4

Vance Thompson Vision

Sioux Falls, South Dakota, United States, 57108

Actively Recruiting

5

The Eye Centers of Racine and Kenosha, LTD

Kenosha, Wisconsin, United States, 53142

Actively Recruiting

Loading map...

Research Team

P

Patricia Buehler, MD

CONTACT

B

Becky Weathers

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here